MYHEP D VIR contains two direct-acting antivirals: Sofosbuvir (NS5B polymerase inhibitor) and Daclatasvir (NS5A inhibitor). Together, they block HCV replication and reduce viral mutation risk.
Recommended for:
Take one tablet orally once daily, with or without food. Duration of treatment is typically 12 weeks and should be determined by a healthcare provider based on genotype and liver condition.
Contraindications:
Side Effects: